Sign in

CIK 0001061983

  • Large accelerated filer

CYTOKINETICS INC

Sign in to watch
Ticker
CYTK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
943291317
Phone
+1 650-624-3000
Business address
350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$13,320,469
in 18 filings, $12.5M under 10b5-1 plans

Net −$13,320,469. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-11-15 Blum Robert I President & CEO Exercise or conversion · Non-Qualified Stock Option (Right to Buy) 10b5-1 −12,500 193,494
2023-11-09 Malik Fady Ibraham EVP Research & Development Sale 10b5-1 −2,500 $35.40 $89K 150,664
2023-10-30 Blum Robert I President & CEO Exercise or conversion 10b5-1 +12,500 $6.67 $83K 453,917
2023-10-30 Blum Robert I President & CEO Sale 10b5-1 −12,500 $32.17 $402K 441,417
2023-10-30 Blum Robert I President & CEO Exercise or conversion · Non-Qualified Stock Option (Right to Buy) 10b5-1 −12,500 205,994
2023-10-16 Blum Robert I President & CEO Exercise or conversion 10b5-1 +12,500 $6.67 $83K 453,917
2023-10-16 Blum Robert I President & CEO Sale 10b5-1 −12,500 $33.70 $421K 441,417
2023-10-16 Blum Robert I President & CEO Exercise or conversion · Non-Qualified Stock Option (Right to Buy) 10b5-1 −12,500 218,494
2023-10-12 Malik Fady Ibraham EVP Research & Development Sale 10b5-1 −2,500 $35.89 $90K 153,164
2023-10-06 Blum Robert I President & CEO Exercise or conversion 10b5-1 +12,500 $6.67 $83K 453,917
2023-10-06 Blum Robert I President & CEO Sale 10b5-1 −12,500 $30.00 $375K 441,417
2023-10-06 Blum Robert I President & CEO Exercise or conversion · Non-Qualified Stock Option (Right to Buy) 10b5-1 −12,500 230,994
2023-10-02 Harrington Robert Arthur Director Grant or award +448 $27.88 $12K 11,373
2023-10-02 HENDERSON JOHN T Director Grant or award +762 $27.88 $21K 31,818
2023-10-02 Kaye Edward M. MD Director Grant or award +448 $27.88 $12K 19,169
2023-10-02 SMITH SANDFORD D Director Grant or award +448 $27.88 $12K 18,653
2023-10-02 WIERENGA WENDALL Director Grant or award +448 $27.88 $12K 18,653
2023-10-02 Wysenski Nancy Director Grant or award +224 $27.88 $6K 17,082
2023-09-14 Malik Fady Ibraham EVP Research & Development Sale 10b5-1 −2,500 $34.86 $87K 155,664
2023-09-13 Blum Robert I President & CEO Exercise or conversion 10b5-1 +12,500 $6.67 $83K 453,917

Page 38 of 45 · 885 trades